Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Rhea-AI Summary
Apyx Medical (NASDAQ: APYX) announced that Renuvion won the 2026 NewBeauty Award for Best Minimally Invasive Skin Tightener, marking a consecutive win and third-party recognition of its clinical impact and market position.
According to the company, Renuvion is FDA-cleared for use following liposuction and pairs with the AYON platform to broaden physician workflow and procedural options.
Positive
- None.
Negative
- None.
News Market Reaction – APYX
In the Apr 1 session, APYX declined 1.63%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin.
"We're proud to be recognized by NewBeauty again," said Charlie Goodwin, President and CEO of Apyx Medical. "This award reflects the real impact Renuvion has for both physicians and their patients. Together with our provider community, we're helping more people achieve visible, confidence-building results through advanced, minimally invasive procedures. As the #1 trusted body contouring technology by surgeons², Renuvion continues to expand what's possible, equipping physicians to deliver consistent outcomes patients can see and feel."
Renuvion is the only device FDA-cleared for use following liposuction, advancing body contouring capabilities. Now combined with the AYON platform, it expands physician offerings by streamlining workflows, increasing procedural efficiency, and enabling more comprehensive, customizable treatment approaches.
Leading up to the 16th annual Awards Issue, NewBeauty editors evaluated thousands of products and treatments to identify the most innovative beauty solutions. Working closely with board-certified physicians and medical experts, they highlighted the most effective, results-driven technologies shaping the future of aesthetics.
To learn more about how Renuvion supports advanced body contouring procedures and to find a provider near you, visit www.Renuvion.com
1. Renuvion is intended for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. Soft tissue includes subcutaneous tissue. Renuvion is intended for the coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring.
2. 4 out of 5 surgeons agree Renuvion is the #1 trusted body contouring technology. Results based on a 2024 Renuvion Physician survey conducted by Wakefield Research. Data on file.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com
Media Contact:
marketing@apyxmedical.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/renuvion-wins-2026-newbeauty-award-for-best-minimally-invasive-skin-tightener-302730789.html
SOURCE Apyx Medical Corporation